Xiamen Humanity Hospital
Adenocarcinoma treatment cost in China typically includes diagnostics like gastroscopy, which ranges from Price on request to Price on request , and surgical interventions like lung cancer surgery, which runs from $24,500 to $43,500. Radiation therapy for colorectal cancer costs $27,500 to $11,500. Total expenses depend on the cancer stage and hospital tier. Patients can save 50-85% compared to the United States. Top treatment centers are located in Guangzhou, Xiamen, and Shanghai.
Typical Adenocarcinoma Treatment Costs in China
Bookimed Expert Insight: Advanced stage patients find the best value at multidisciplinary facilities like Fuda Cancer Hospital. They offer specialized NanoKnife and cryosurgery for complex cases. For those requiring precision radiotherapy, Xiamen Humanity Hospital provides expert care under senior oncology leadership. Early-stage patients benefit from JCI-accredited centers that ensure international safety standards while maintaining high savings. Multimodel approaches at these tertiary hospitals are most effective for thoracic and abdominal malignancies.
| China | Turkey | Austria | |
| Whipple surgery | from $28,500 | from $16,200 | from $45,000 |
| Uterine Trachelectomy | from $9,800 | from $5,500 | from $14,500 |
| Robotic da Vinci prostatectomy | from $18,800 | from $13,000 | from $20,000 |
| Radiation therapy for colorectal cancer | from $11,500 | from $7,000 | from $12,000 |
| Proton-beam therapy | from $36,500 | from $70,000 | from $80,000 |
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.
Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.
Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).
Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.
Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.
Dr. Niu Lizhi is the President and chief surgeon at Fuda Cancer Hospital in Guangzhou. He has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures. Dr. Niu specializes in minimally invasive oncology for lung, pancreatic, and liver cancers. He treats patients ranging from early childhood through age 94.
China offers unique adenocarcinoma treatments including CAR-T therapy for solid tumors and early-access oncolytic viruses. Facilities like Fuda Cancer Hospital specialize in minimally invasive cryoimmunotherapy for advanced stages. These protocols often receive regulatory approval years before Western markets. Patients access specific therapies targeting the Claudin18.2 protein.
Bookimed Expert Insight: China is a hub for late-stage cancer care because facilities like Fuda Cancer Hospital combine over 10 types of minimally invasive therapies. Our data shows hospitals here often manage 1,000,000 patients annually. This high volume allows surgeons to refine techniques like NanoKnife and microwave hyperthermia faster than in lower-volume regions. This practical experience is vital for complex adenocarcinoma cases.
Patient Consensus: Patients note that seeking treatment in China often provides earlier access to experimental therapies through active clinical trials. Many emphasize the importance of consulting both local and international oncologists to verify efficacy data before starting newer immunotherapy combinations.
Traditional Chinese Medicine (TCM) is frequently integrated with standard adenocarcinoma treatments in China to enhance outcomes. This integrated approach combines Western tumor-targeting therapies with TCM's holistic focus. It helps mitigate side effects like nausea or fatigue from chemotherapy while supporting the patient’s immune system through recovery.
Bookimed Expert Insight: Patient data from Jinshazhou Hospital of Guangzhou University of Chinese Medicine reveals a significant trend where advanced technologies like CyberKnife M6 are physically housed within TCM-affiliated institutions. This proximity suggests that integration isn't just a philosophy but a structural reality in China. For around $7,700, patients can access high-precision radiosurgery packages that already include the necessary medical consultations for a combined treatment plan.
Patient Consensus: Patients emphasize that TCM should be a side-by-side support rather than a replacement for surgery or chemotherapy. Many note it is essential to disclose herbal use to oncologists to avoid potential liver metabolism interactions.
Beijing, Shanghai, and Guangzhou are the primary hubs for cancer care in China. These cities host national centers like the Cancer Hospital of the Chinese Academy of Medical Sciences. Facilities often feature Joint Commission International (JCI) accreditation and specialize in advanced therapies like CyberKnife and NanoKnife.
Bookimed Expert Insight: Guangzhou holds a unique position for international patients due to a concentration of minimally invasive technologies. Fuda Cancer Hospital has treated over 30,000 international patients using specialized cryosurgery and NanoKnife protocols. While Beijing centers focus on national research, Guangzhou clinics often provide more accessible high-tech packages. For instance, CyberKnife M6 treatments in the region cost around $7,700 and include transfers and hotel stays.
Patient Consensus: Patients emphasize bringing original pathology slides to avoid diagnostic delays. They note that JCI-accredited facilities provide better English support and more organized care transitions for international visitors.
Foreign patients in China usually pay 100% upfront for adenocarcinoma treatments. Most hospitals require proof of funds for admission. Large payments typically move via wire transfer, Alipay, or WeChat Pay. International health insurance often requires pre-authorization 2 to 4 weeks before arrival.
Bookimed Expert Insight: CyberKnife M6 packages in Guangzhou, costing approximately 56,000 CNY, often exclude hospital stays. Our data shows specialized centers like Fuda Cancer Hospital serve 30,000+ international patients. These JCI-accredited facilities often require separate budgeting for hotel accommodation. Always confirm which services are bundled to avoid payment delays.
Patient Consensus: Patients note that foreign credit cards often fail for large medical bills. They recommend having high-limit bank transfers or local mobile payment apps ready. Many found that international insurers might label certain advanced therapies as experimental, making upfront cash essential.
Chinese hospitals manage international patients through dedicated international departments providing on-site medical interpreters and JCI-accredited coordination services. Logistics often include visa assistance, airport transfers, and digital communication tools like WeChat groups. Integrated packages typically bundle surgical consultations, medication, and local transportation for seamless care.
Bookimed Expert Insight: While top-tier facilities like Fuda Cancer Hospital serve thousands of international patients, logistics vary by city. Packages at Jinshazhou Hospital in Guangzhou often include clinic transfers. However, Xiamen Humanity Hospital serves nearly 1,000,000 patients annually. Choosing high-volume centers ensures streamlined administrative protocols for foreign medical records and faster visa processing.
Patient Consensus: Patients note that doctors often speak fluent English, but nursing staff may not. They recommend setting up digital payment apps and hiring local student fixers to help navigate daily hospital bureaucracy.